Filed: 8/12/2026ACC: 0001193125-26-347068
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $162.61M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$162.61M
Total AUM (reported)
21.96M
Total Shares
Allocation by class
COMMON STOCK$154.50M95.0%
COMMON SHARES$8.12M5.0%
Portfolio Concentration
Top 3$128.82M79.2%
4–10$33.79M20.8%
Top 3 weight
79.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 21.96M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
21.96M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other8
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings8
Rows:
Monte Rosa Therapeutics, Inc.
OTRShares3.18M
TypeSH
Market value$76.97M
47.34%
Sole
0.00
Shared
3.18M
None
0.00
Century Therapeutics, Inc.
OTRShares12.17M
TypeSH
Market value$29.81M
18.33%
Sole
0.00
Shared
12.17M
None
0.00
Jade Biosciences, Inc.
OTRShares991.78K
TypeSH
Market value$22.04M
13.55%
Sole
0.00
Shared
991.78K
None
0.00
Lenz Therapeutics, Inc.
OTRShares2.66M
TypeSH
Market value$15.09M
9.28%
Sole
0.00
Shared
2.66M
None
0.00
Contineum Therapeutics, Inc.
OTRShares542.63K
TypeSH
Market value$8.89M
5.47%
Sole
0.00
Shared
542.63K
None
0.00
CRISPR Therapeutics AG
OTRShares148.83K
TypeSH
Market value$8.12M
4.99%
Sole
0.00
Shared
148.83K
None
0.00
Skye Bioscience, Inc.
OTRShares2.01M
TypeSH
Market value$1.39M
0.86%
Sole
0.00
Shared
2.01M
None
0.00
Tempest Therapeutics, Inc.
OTRShares269.77K
TypeSH
Market value$299.4K
0.18%
Sole
0.00
Shared
269.77K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc.OTR | Common Stock | 3.18M | SH | $76.97M 47.34% | 0.00 | 3.18M | 0.00 |
Century Therapeutics, Inc.OTR | Common Stock | 12.17M | SH | $29.81M 18.33% | 0.00 | 12.17M | 0.00 |
Jade Biosciences, Inc.OTR | Common Stock | 991.78K | SH | $22.04M 13.55% | 0.00 | 991.78K | 0.00 |
Lenz Therapeutics, Inc.OTR | Common Stock | 2.66M | SH | $15.09M 9.28% | 0.00 | 2.66M | 0.00 |
Contineum Therapeutics, Inc.OTR | Common Stock | 542.63K | SH | $8.89M 5.47% | 0.00 | 542.63K | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 148.83K | SH | $8.12M 4.99% | 0.00 | 148.83K | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $1.39M 0.86% | 0.00 | 2.01M | 0.00 |
Tempest Therapeutics, Inc.OTR | Common Stock | 269.77K | SH | $299.4K 0.18% | 0.00 | 269.77K | 0.00 |